Effect of blood cyclosporine concentration on the outcome of hematopoietec stem cell transplantation from an HLA-matched sibling donor

Yoshinobu Kanda, Rie Hyo, Takuya Yamashita, Katsumichi Fujimaki, Kumi Oshima, Masahiro Onoda, Takehiko Mori, Toru Sakura, Masatsugu Tanaka, Miwa Sakai, Jun Taguchi, Mineo Kurakawa, Atsuo Maruta, Shinichiro Okamoto, Hisashi Sakamaki

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

We retrospectively evaluated the effect of the blood cyclosporine (CsA) concentration on the outcome of allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in 171 patients who received a continuous infusion of CsA and short-course methotrexate to prevent graft-versus-host disease (GVHD). CsA was started at 3.0 mg/kg/day and the dose was adjusted to maintain the blood CsA concentration between 250 and 350 ng/ml. The actual dose of CsA averaged 1.9 mg/kg/day at the 3rd week after transplantation. The incidence of grade II-IV acute GVHD was 29.9%. Patient age and sex were identified as independent significant risk factors for acute GVHD. The CsA concentration during the 3rd week after transplantation most strongly affected the incidence of grade II-IV acute GVHD (RR 0.995 for an increase in CsA concentration by 1 ng/ml, P = 0.037) adjusted for other risk factors. The incidence of acute GVHD was significantly lower in patients with a 3rd-week CsA concentration higher than 300 ng/ml than in those with values between 200 and 300 ng/ml (20% vs. 35%, P = 0.036). We concluded that the blood CsA concentration at peri-engraftment period may be important in preventing acute GVHD.

Original languageEnglish
Pages (from-to)838-844
Number of pages7
JournalAmerican Journal of Hematology
Volume81
Issue number11
DOIs
Publication statusPublished - 2006 Nov

Fingerprint

Stem Cell Transplantation
Graft vs Host Disease
Cyclosporine
Siblings
Tissue Donors
Incidence
Transplantation
Hematopoietic Stem Cell Transplantation
Methotrexate

Keywords

  • Blood concentration
  • Continuous infusion
  • Cyclosporine
  • Graft-versus-host disease
  • Hematopoietic stem cell transplantation

ASJC Scopus subject areas

  • Hematology

Cite this

Effect of blood cyclosporine concentration on the outcome of hematopoietec stem cell transplantation from an HLA-matched sibling donor. / Kanda, Yoshinobu; Hyo, Rie; Yamashita, Takuya; Fujimaki, Katsumichi; Oshima, Kumi; Onoda, Masahiro; Mori, Takehiko; Sakura, Toru; Tanaka, Masatsugu; Sakai, Miwa; Taguchi, Jun; Kurakawa, Mineo; Maruta, Atsuo; Okamoto, Shinichiro; Sakamaki, Hisashi.

In: American Journal of Hematology, Vol. 81, No. 11, 11.2006, p. 838-844.

Research output: Contribution to journalArticle

Kanda, Y, Hyo, R, Yamashita, T, Fujimaki, K, Oshima, K, Onoda, M, Mori, T, Sakura, T, Tanaka, M, Sakai, M, Taguchi, J, Kurakawa, M, Maruta, A, Okamoto, S & Sakamaki, H 2006, 'Effect of blood cyclosporine concentration on the outcome of hematopoietec stem cell transplantation from an HLA-matched sibling donor', American Journal of Hematology, vol. 81, no. 11, pp. 838-844. https://doi.org/10.1002/ajh.20710
Kanda, Yoshinobu ; Hyo, Rie ; Yamashita, Takuya ; Fujimaki, Katsumichi ; Oshima, Kumi ; Onoda, Masahiro ; Mori, Takehiko ; Sakura, Toru ; Tanaka, Masatsugu ; Sakai, Miwa ; Taguchi, Jun ; Kurakawa, Mineo ; Maruta, Atsuo ; Okamoto, Shinichiro ; Sakamaki, Hisashi. / Effect of blood cyclosporine concentration on the outcome of hematopoietec stem cell transplantation from an HLA-matched sibling donor. In: American Journal of Hematology. 2006 ; Vol. 81, No. 11. pp. 838-844.
@article{21146f7dcf9a4aaeb23f6c1d419028a6,
title = "Effect of blood cyclosporine concentration on the outcome of hematopoietec stem cell transplantation from an HLA-matched sibling donor",
abstract = "We retrospectively evaluated the effect of the blood cyclosporine (CsA) concentration on the outcome of allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in 171 patients who received a continuous infusion of CsA and short-course methotrexate to prevent graft-versus-host disease (GVHD). CsA was started at 3.0 mg/kg/day and the dose was adjusted to maintain the blood CsA concentration between 250 and 350 ng/ml. The actual dose of CsA averaged 1.9 mg/kg/day at the 3rd week after transplantation. The incidence of grade II-IV acute GVHD was 29.9{\%}. Patient age and sex were identified as independent significant risk factors for acute GVHD. The CsA concentration during the 3rd week after transplantation most strongly affected the incidence of grade II-IV acute GVHD (RR 0.995 for an increase in CsA concentration by 1 ng/ml, P = 0.037) adjusted for other risk factors. The incidence of acute GVHD was significantly lower in patients with a 3rd-week CsA concentration higher than 300 ng/ml than in those with values between 200 and 300 ng/ml (20{\%} vs. 35{\%}, P = 0.036). We concluded that the blood CsA concentration at peri-engraftment period may be important in preventing acute GVHD.",
keywords = "Blood concentration, Continuous infusion, Cyclosporine, Graft-versus-host disease, Hematopoietic stem cell transplantation",
author = "Yoshinobu Kanda and Rie Hyo and Takuya Yamashita and Katsumichi Fujimaki and Kumi Oshima and Masahiro Onoda and Takehiko Mori and Toru Sakura and Masatsugu Tanaka and Miwa Sakai and Jun Taguchi and Mineo Kurakawa and Atsuo Maruta and Shinichiro Okamoto and Hisashi Sakamaki",
year = "2006",
month = "11",
doi = "10.1002/ajh.20710",
language = "English",
volume = "81",
pages = "838--844",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - Effect of blood cyclosporine concentration on the outcome of hematopoietec stem cell transplantation from an HLA-matched sibling donor

AU - Kanda, Yoshinobu

AU - Hyo, Rie

AU - Yamashita, Takuya

AU - Fujimaki, Katsumichi

AU - Oshima, Kumi

AU - Onoda, Masahiro

AU - Mori, Takehiko

AU - Sakura, Toru

AU - Tanaka, Masatsugu

AU - Sakai, Miwa

AU - Taguchi, Jun

AU - Kurakawa, Mineo

AU - Maruta, Atsuo

AU - Okamoto, Shinichiro

AU - Sakamaki, Hisashi

PY - 2006/11

Y1 - 2006/11

N2 - We retrospectively evaluated the effect of the blood cyclosporine (CsA) concentration on the outcome of allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in 171 patients who received a continuous infusion of CsA and short-course methotrexate to prevent graft-versus-host disease (GVHD). CsA was started at 3.0 mg/kg/day and the dose was adjusted to maintain the blood CsA concentration between 250 and 350 ng/ml. The actual dose of CsA averaged 1.9 mg/kg/day at the 3rd week after transplantation. The incidence of grade II-IV acute GVHD was 29.9%. Patient age and sex were identified as independent significant risk factors for acute GVHD. The CsA concentration during the 3rd week after transplantation most strongly affected the incidence of grade II-IV acute GVHD (RR 0.995 for an increase in CsA concentration by 1 ng/ml, P = 0.037) adjusted for other risk factors. The incidence of acute GVHD was significantly lower in patients with a 3rd-week CsA concentration higher than 300 ng/ml than in those with values between 200 and 300 ng/ml (20% vs. 35%, P = 0.036). We concluded that the blood CsA concentration at peri-engraftment period may be important in preventing acute GVHD.

AB - We retrospectively evaluated the effect of the blood cyclosporine (CsA) concentration on the outcome of allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in 171 patients who received a continuous infusion of CsA and short-course methotrexate to prevent graft-versus-host disease (GVHD). CsA was started at 3.0 mg/kg/day and the dose was adjusted to maintain the blood CsA concentration between 250 and 350 ng/ml. The actual dose of CsA averaged 1.9 mg/kg/day at the 3rd week after transplantation. The incidence of grade II-IV acute GVHD was 29.9%. Patient age and sex were identified as independent significant risk factors for acute GVHD. The CsA concentration during the 3rd week after transplantation most strongly affected the incidence of grade II-IV acute GVHD (RR 0.995 for an increase in CsA concentration by 1 ng/ml, P = 0.037) adjusted for other risk factors. The incidence of acute GVHD was significantly lower in patients with a 3rd-week CsA concentration higher than 300 ng/ml than in those with values between 200 and 300 ng/ml (20% vs. 35%, P = 0.036). We concluded that the blood CsA concentration at peri-engraftment period may be important in preventing acute GVHD.

KW - Blood concentration

KW - Continuous infusion

KW - Cyclosporine

KW - Graft-versus-host disease

KW - Hematopoietic stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=33750593651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750593651&partnerID=8YFLogxK

U2 - 10.1002/ajh.20710

DO - 10.1002/ajh.20710

M3 - Article

C2 - 16888784

AN - SCOPUS:33750593651

VL - 81

SP - 838

EP - 844

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 11

ER -